Similar Papers

Paper Title
Journal
Date
Author
Tumor Necrosis Factor Receptor Expression on Human Normal and Malignant B Lymphocytes: Anti-75-kDa Tumor Necrosis Factor Receptor Antibody Inhibits B-Cell Proliferation
B. Heilig ... T. Kubin
-
B. Heilig, et. al.B. Heilig ... T. Kubin
01 Jan 1992
The Systemic Inflammatory Response to Cardiopulmonary Bypass
Richard I Hall ... Mark Stafford Smith
Anesthesia & Analgesia | VOL. 85
Richard I Hall, et. al.Richard I Hall ... Mark Stafford Smith
01 Oct 1997
Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.
L.A Tartaglia ... D.V Goeddel
Journal of Biological Chemistry | VOL. 268
L.A Tartaglia, et. al.L.A Tartaglia ... D.V Goeddel
01 Sep 1993
Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.
F W Jacobsen ... L Rusten
Proceedings of the National Academy of Sciences | VOL. 91
F W Jacobsen, et. al.F W Jacobsen ... L Rusten
25 Oct 1994
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.